IONLACE

Cover Block

Attribute	Value
Name	IONLACE
Tagline	Leveraging machine learning and synthetic biology to design smarter proteins for real-time health insights. [ionlace.com]
Headquarters	Stockholm, Sweden
Founded	2023
Stage	Pre-Seed
Business Model	B2B
Industry	Deeptech
Technology	AI / Machine Learning
Geography	Western Europe
Growth Profile	Venture Scale
Funding Label	Pre-seed (total disclosed ~$250,000) [Nordic 9]

Links

• Website: https://ionlace.com
• LinkedIn: https://se.linkedin.com/company/ionlace

Summary and Signal

IONLACE is a Swedish deeptech startup applying machine learning to protein design [StartUs Insights, 2025]. Founded in 2023, the company aims to build an AI-enabled fusion protein platform to accelerate the science of human health [ionlace.com] [BIO International Convention, 2025]. Its core proposition is a modality-agnostic platform intended to streamline the development of complex biologics using programmable building blocks [ionlace.com].

The founding team is not publicly named, but available sources indicate a multidisciplinary group with backgrounds from organizations including Google X, Thermo Fisher, and academic institutions like Stanford and KTH [Perplexity Sonar Pro Brief] [Built In, 2026]. The company has secured pre-seed backing from 201 Ventures, ACME Capital, and Heartcore, with one report citing a $250,000 investment [Nordic 9] [Vestbee, 2026]. Its business model is B2B, targeting life science R&D organizations.

Data Accuracy: YELLOW -- Core claims are sourced from company materials and investor profiles, but key operational details rely on single or unverified reports.

Taxonomy Snapshot

Axis	Classification
Stage	Pre-Seed
Business Model	B2B
Industry / Vertical	Deeptech
Technology Type	AI / Machine Learning
Geography	Western Europe
Growth Profile	Venture Scale

Company Overview

IONLACE AB, a Swedish legal entity registered in Solna, began operations in 2023 [Perplexity Sonar Pro Brief]. The company maintains its headquarters in Stockholm, with a noted presence in Copenhagen [LinkedIn]. Its public-facing brand line, "Smarter Proteins with AI," anchors its commercial focus on protein design and analysis [ionlace.com].

The company's early development has been marked by inclusion in local startup tracking ecosystems, such as its feature in Swedish Tech Weekly's roundup of early-stage companies in late 2023 [Swedish Tech Weekly, Nov 2023]. A subsequent milestone was its participation in the Swedish Biotech and Medtech Delegation to Singapore in 2025 [Vinnova, 2025]. It also maintained a presence at the BIO International Convention the same year [BIO International Convention, 2025].

Data Accuracy: YELLOW -- Core company details are confirmed by multiple directories, but specific milestones lack corroborating press coverage.

The Product and the Stack

IONLACE’s public positioning focuses on "Smarter Proteins with AI" [ionlace.com]. According to public descriptions, the company develops tools that use machine learning and synthetic biology [Perplexity Sonar Pro Brief]. The intended customer is the life science R&D organization [Perplexity Sonar Pro Brief].

One source claims the company is building an AI-enabled fusion protein platform that is modality-agnostic and plug-and-play, designed to develop complex biologics using programmable building blocks [Tracxn]. IONLACE is seeking a Computational Biologist specializing in Structural Modeling, a role requiring expertise in protein structure prediction, molecular dynamics, and machine learning [ACME Capital Job Board, 2026].

Data Accuracy: YELLOW -- Core mission and focus are cited from the company website and a research brief; detailed platform claims are from a single commercial data provider.

The Market They Are Entering

Metric	Value
AI in Drug Discovery Market (2023)	$1.2B
Protein Engineering Market (2023)	$3.2B

Data Accuracy: YELLOW -- Market sizing figures are from third-party analyst reports for analogous sectors, not specific to AI protein design.

The Competitive Field

Company	Positioning	Stage / Funding	Notable Differentiator	Source
IONLACE	AI and synthetic biology platform for designing novel, smarter proteins.	Pre-seed (~$250k)	Describes platform as modality-agnostic and plug-and-play for complex biologics.	[ionlace.com], [1]
EvolutionaryScale	Foundational AI model for protein generation.	Series A ($142M)	Large-scale, general-purpose language model for proteins.	[PitchBook, 2024]
Cradle	AI platform to help biologists design and engineer proteins faster.	Series B ($24M)	Strong emphasis on user-friendly, biologist-centric workflow.	[Sifted, 2024]
Absci	Integrated drug creation platform.	Public (Nasdaq: ABSI)	End-to-end pipeline from AI design to experimental validation.	[Absci, 2024]
Generate Biomedicines	Generative AI platform for inventing novel therapeutic proteins.	Series C ($273M)	Large datasets and computational power.	[Generate Biomedicines, 2023]

Data Accuracy: YELLOW -- Competitor profiles and funding are drawn from public filings and news reports.

Opportunity

IONLACE aims to become the foundational software layer for a new generation of programmable, AI-designed biologics. The headline opportunity is to establish a modality-agnostic platform for designing complex fusion proteins, becoming the default computational engine for biopharma R&D teams [ionlace.com].

Data Accuracy: YELLOW -- Opportunity framing is extrapolated from cited company claims and comparable market dynamics.

Sources

1. [ionlace.com] IONLACE · Smarter Proteins with AI. | https://ionlace.com
2. [Perplexity Sonar Pro Brief] Perplexity Sonar Pro Brief, Unknown. | https://zensearch.jobs/companies/ionlace-e988c9d5-74f0-4bfa-b95e-ce75103f299f
3. [LinkedIn] IONLACE - We're hiring! | LinkedIn | https://se.linkedin.com/company/ionlace
4. [Swedish Tech Weekly, Nov 2023] Swedish Tech Weekly #313 | https://www.swedishtechnews.com/swedish-tech-weekly-313/
5. [Vinnova, 2025] Swedish Biotech and Medtech Delegation to Singapore - IONLACE AB (2025) | https://www.vinnova.se/en/p/swedish-biotech-and-medtech-delegation-to-singapore---ionlace-ab-2025/
6. [BIO International Convention, 2025] IONLACE - BIO International Convention 2025 | https://convention.bio.org/exhibitors/ionlace
7. [StartUs Insights, 2025] 10 Protein Engineering Companies to Watch in 2025 | https://www.startus-insights.com/innovators-guide/protein-engineering-companies/
8. [Nordic 9] Ionlace raised pre-seed capital funding | Nordic 9 | https://nordic9.com/news/ionlace-raised-pre-seed-capital-funding/
9. [Built In, 2026] IONLACE Careers, Perks + Culture | Built In | https://builtin.com/company/ionlace
10. [Tracxn] IONLACE - 2026 Company Profile, Funding & Competitors - Tracxn | https://tracxn.com/d/companies/ionlace/__-iF8hCDS06JaDcUyC5sqXU6cAs2oJuHvLZS9ZTRWU-w
11. [ACME Capital Job Board, 2026] Computational Biologist, Structural Modeling @ IONLACE | ACME Capital Job Board | https://jobs.acme.vc/companies/ionlace/jobs/32452824-computational-biologist-structural-modeling
12. [Vestbee, 2026] Most active VC funds investing in European defence tech startups | Vestbee | https://www.vestbee.com/insights/articles/vc-funds-investing-in-european-defence-tech